Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells

Journal of Immunology

Volumn 166, Issue 12, 2001, Pages 7571-7578

  Salcedo, R ^a   Young, H A ^a   Ponce, M L ^a   Ward, J M ^a   Kleinman, H K ^a   Murphy, W J ^a   Oppenheim, J J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CHEMOKINE; CHEMOKINE RECEPTOR CCR3; EOTAXIN; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHEMOTAXIS; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; EOSINOPHIL; HUMAN; HUMAN CELL; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0035877258     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.12.7571     Document Type: Article

References (44)

1. The role of CXC chemokines as regulators of angiogenesis
2. The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer
3. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis
4. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1α
5. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
6. Human endothelial cells express CCR2 and respond to MCP-1: Direct role of MCP-1 in angiogenesis and tumor progression
7. Cloning of the human eosinophil chemoattractant, eotaxin: Expression, receptor binding and functional properties suggest a mechanism for the selective recruitment of eosinophils
8. Eotaxin and eosinophil recruitment: Implications for human disease
9. Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation
10. Eotaxin is a potent chemotaxin for human basophils
11. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells
12. Chemokine receptors in the human brain and their relationship to HIV infection
13. CXC and CC chemokine receptors on coronary and brain endothelia
14. Differential chemokine expression in tissues involved by Hodgkin's disease: Direct correlation of eotaxin expression and tissue eosinophilia
15. Eotaxin and capping protein in experimental vasculopathy
16. A highly sensitive model for quantification of in vivo tumor angiogenesis induced by alginate-encapsulated tumor cells
17. Expression of transforming growth factors-α and β1 messenger RNA and product by eosinophils in nasal polyps
18. Chymase mediates mast cell-induced angiogenesis in hamster sponge granulomas
19. Chymase as a proangiogenic factor: A possible involvement of chymase-angiotensin-dependent pathway in the hamster sponge angiogenesis model
20. Degranulating eosinophils in human endometriosis
21. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines
22. Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10
23. Gene transfer of IFN-γ into established brain tumors represses growth by anti-angiogenesis
24. Tumor cell responses to IFN γ, affect tumorigenicity and response to IL-12 therapy and anti-angiogenesis
25. Induction of eotaxin expression and release from human airway smooth muscle cells by IL-Iβ and TNFCα: Effects of IL-10 and corficosteroids
26. Th1-derived cytokine IFN-γ is a potent inhibitor of eotaxin synthesis in vitro
27. Interleukin-13 and tumor necrosis factor-α synergistically induce eotaxin production in human nasal fibroblasts
28. Eosinophils and human cancer
29. Eosinophil predominance in Hodgkin's disease
30. Prognostic factors for well-differentiated squamous cell carminoma in the oral cavity with emphasis on immunohistochemical evalutation
31. A case of gastric carcinoma with massive eosinophilia and squamous differentiation: Histochemical, immunohistochemical and ultrastructural aspects
32. Carcinoma of the cervix with massive eosinophilia
33. Local responses in primary and secondary human lung cancers. II. Clinical correlations
34. Eosinophil infiltration of human colonic carcinomas as a prognostic indicator
35. Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma
36. + lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4
37. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells
38. Chemokine receptors in human endothelial cells: Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines
39. Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR4/fusin) under the control of autocrine activity and exogenous cytokines
40. I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo
41. Antigen-induced eosinophilic lung inflammation develops in mice deficient in chemokine CCL11
42. Eotaxin is required for the baseline level of tissue eosinophils
43. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia
44. Chemokines IL-8, GRO α, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing